AB015. Current diagnostic approaches in ILD: ILD vs. non-specialty clinics

Autor:	Fernando J. Martinez, Sherry Danese, Michael J. Rosenbluth, Elizabeth A. Belloli, Pauline Bianchi, Kevin R. Flaherty, Yoonha Choi
Jazyk:	angličtina
Rok vydání:	2016
Předmět:	Pulmonary and Respiratory Medicine medicine.medical_specialty High-resolution computed tomography Specialty Diagnostic evaluation behavioral disciplines and activities 03 medical and health sciences Idiopathic pulmonary fibrosis chemistry.chemical_compound 0302 clinical medicine medicine 030212 general & internal medicine Intensive care medicine Pulmonologists medicine.diagnostic_test business.industry Pulmonologist Pirfenidone respiratory system medicine.disease respiratory tract diseases 3. Good health body regions 030228 respiratory system chemistry Physical therapy Nintedanib Session 1.2: Diagnostic Practice business medicine.drug
Popis:	Background The approach to diagnosing interstitial lung diseases (ILDs) has evolved. While high resolution computed tomography (HRCT) and multidisciplinary discussion are key components in the diagnostic process, the approval of pirfenidone and nintedanib for idiopathic pulmonary fibrosis (IPF) has spurred greater urgency to improve the diagnostic process. In this study, we evaluated responses from pulmonologist in ILD and non-specialty clinics to assess the current ILD diagnostic evaluation and impact of a novel genomic classifier under development.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5e3c1b7a7c1aa228514be01c0c45188 https://europepmc.org/articles/PMC4958742/ Zobrazit plný text záznamu